Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,830.47
    -46.58 (-0.59%)
     

  • Bitcoin USD

    64,841.74
    +2,141.02 (+3.41%)
     

  • CMC Crypto 200

    1,334.09
    +21.46 (+1.66%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,390.30
    -7.70 (-0.32%)
     

  • Crude Oil

    81.97
    -0.76 (-0.92%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Company News For Nov 27, 2019

Zacks Equity Research

  • Shares of ChemoCentryx, Inc. CCXI gained more than 100% after the clinical-stage biopharmaceutical company reported that the pivotal phase-III ADVOCATE trial of avacopan for treatment of patients with ANCA-associated vasculitis had met both primary endpoints.

  • Shares of Safehold Inc. SAFE rose 6.9% after the company would replace Oritani Financial in the S&P SmallCap 600 on December 3.

  • Shares of Titan Machinery Inc. TITN declined 15.5% after the company reported third quarter earnings of $0.44 per share, which missed the Zacks Consensus Estimate of $0.47.

  • Shares of Hewlett Packard Enterprise Company HPE lost 8.5% after the company’s net revenues of $7.23 billion missed the Zacks Consensus Estimate of $7.46 billion.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Hewlett Packard Enterprise Company (HPE) : Free Stock Analysis Report
 
Titan Machinery Inc. (TITN) : Free Stock Analysis Report
 
ChemoCentryx, Inc. (CCXI) : Free Stock Analysis Report
 
Safehold Inc. (SAFE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research